Keyword: Ipca Laboratories
Chloroquine fails in China study, as India bans its export. China halts BeiGene's Abraxane supply. MET inhibitor Tepmetko wins first global nod.
The Indian export agency is cutting off supplies to the U.S. of the malaria drug that some sees as a potential treatment for COVID-19.
Ipca Laboratories says the FDA is lifting a ban on products from two plants so it can ship hydroxychloroquine sulphate and chloroquine phosphate APls.
BeiGene rebuffs claims that it inflated drug sales records; Sumitomo Dainippon pays $3 billion upfront for five "vants"; Genentech settles with JHL Biotech.
An Ipca Labs plant savaged in an FDA warning letter three years ago continues to fail manufacturing standards that would assure its drugs are safe.